Could Sonnet BioTherapeutics Holdings Inc’s (NASDAQ: SONN) Earnings Exceed Your Expectations?
In today’s recent session, 2.49 million shares of the Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) have been traded, and its beta is 0.63. Most recently the